Levitronix LLC, a privately held medical device company, has appointed Suraj Kalia to its advisory board. Presently, he is a senior analyst at SMH Capital (SMH) and has spent his career researching and analyzing healthcare companies, with a specific focus on the medical device sector. Before joining SMH, Kalia was a Senior Analyst at Piper Jaffray, with primary coverage responsibility for the medical device sector.
Prior to this, Kalia held corporate development roles at Entegris, Inc, and was an Adjunct Professor of Finance at the University of St. Thomas in Minnesota. Suraj received a B.Tech in Chemical Engineering from the Indian Institute of Technology; an M.E. in Chemical Engineering from the Stevens Institute of Technology; and an MBA from the University of St. Thomas. He is also a Chartered Financial Analyst.
“We are delighted that Suraj has agreed to join our Advisory Board,” said Kurt Dasse, chief executive officer of Levitronix. “Suraj will add tremendous value to Levitronix with his knowledge of the cardiovascular market, his analytical skills, and technical background. Mr. Kalia will be especially valuable to Levitronix as the Company considers financing options to achieve our strategic growth objectives. We look forward to working with Suraj and to his strategic input as we develop our long range plans.”
“I have been impressed with the depth and breadth of resident expertise at Levitronix, and am excited to be working with a team of dedicated professionals. Given the favorable shift in market dynamics for assist devices, both in the acute and chronic heart-failure space, I believe Levitronix stands to gain significantly in the years to come,” said Kalia.